NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.340
+0.010 (0.75%)
At close: Sep 18, 2026, 4:00 PM EDT
1.320
-0.020 (-1.49%)
After-hours: Sep 18, 2026, 7:30 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $5.77 million as of September 18, 2026. Its market cap has decreased by -23.00% in one year.
Market Cap
5.77M
Enterprise Value
-19.21M
1-Year Change
-23.00%
Ranking
Category
Stock Price
$1.34
ChartMarket Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $5.77M, a decrease of -98.88%. That is a compound annual growth rate of -39.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 5.60M | -62.67% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 6.57M |
| Xenetic Biosciences | 6.49M |
| Creative Medical Technology Holdings | 6.37M |
| AIM ImmunoTech | 6.32M |
| Ernexa Therapeutics | 6.25M |
| Cardio Diagnostics Holdings | 5.98M |
| Kairos Pharma | 5.86M |
| Lexaria Bioscience | 5.35M |